Compare UHAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UHAL | RGEN |
|---|---|---|
| Founded | 1945 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | UHAL | RGEN |
|---|---|---|
| Price | $53.04 | $166.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $170.90 |
| AVG Volume (30 Days) | 181.1K | ★ 813.6K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.19 | 0.03 |
| Revenue | ★ $5,972,459,000.00 | $707,890,000.00 |
| Revenue This Year | $3.18 | $17.50 |
| Revenue Next Year | $3.71 | $12.74 |
| P/E Ratio | ★ $44.35 | $6,528.73 |
| Revenue Growth | 5.86 | ★ 11.74 |
| 52 Week Low | $48.48 | $102.97 |
| 52 Week High | $75.19 | $182.52 |
| Indicator | UHAL | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 61.26 |
| Support Level | $48.48 | $146.56 |
| Resistance Level | $53.14 | $174.01 |
| Average True Range (ATR) | 1.24 | 6.82 |
| MACD | 0.40 | 1.44 |
| Stochastic Oscillator | 86.99 | 74.38 |
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.